Avantor/$AVTR

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About Avantor

Avantor Inc provider of products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company has three geographic segments: the Americas, Europe, and AMEA. The company's product group consists of Equipment & instrumentation, Services & specialty procurement, Proprietary materials & consumables, and Third-party materials & consumables. Materials & consumables include high-purity chemicals and reagents, lab products and supplies, specialized formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, and education and microbiology and clinical trial kits, peristaltic pumps and fluid handling tips.

Ticker

$AVTR
Sector

Primary listing

NYSE

Employees

13,500

Avantor Metrics

BasicAdvanced
$7.9B
-
-$0.13
0.98
-

What the Analysts think about Avantor

Analyst ratings (Buy, Hold, Sell) for Avantor stock.

Bulls say / Bears say

Shares of Avantor jumped 11% to $12.80 after the Wall Street Journal reported on a letter from Engine Capital, showing investor optimism that potential strategic shifts could unlock value (WSJ)
Engine Capital believes Avantor could be sold for $17–$19 per share, suggesting a potential 37–54% gain from current prices (Reuters)
Reuters reports that Emmanuel Ligner has been named CEO starting August 18, 2025, bringing over three decades of life sciences experience as he looks to enhance operations (Reuters)
Activist investor Engine Capital has called for a board overhaul and cost reductions after Avantor shares fell 45% year-to-date, highlighting persistent operational problems (Reuters)
Avantor’s market capitalization has dropped to $7.8 billion after the stock lost nearly 50% this year, indicating ongoing investor doubts about growth prospects (WSJ)
Analysts quoted by Reuters remain cautious about a sale, citing a lack of obvious buyers and pointing to limited strategic options and execution risk (Reuters)
Data summarised monthly by Lightyear AI. Last updated on 8 Nov 2025.

Avantor Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Avantor Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $AVTR

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs
Buy Avantor stock | $AVTR Share Price | Lightyear